295 related articles for article (PubMed ID: 25476898)
1. Enhancing mammary differentiation by overcoming lineage-specific epigenetic modification and signature gene expression of fibroblast-derived iPSCs.
Li Y; Hong N; Zhang A; Chen W; Wang RH; Xu XL; Deng CX
Cell Death Dis; 2014 Dec; 5(12):e1550. PubMed ID: 25476898
[TBL] [Abstract][Full Text] [Related]
2. Generation of Induced Pluripotent Stem Cells from Bovine Epithelial Cells and Partial Redirection Toward a Mammary Phenotype In Vitro.
Cravero D; Martignani E; Miretti S; Accornero P; Pauciullo A; Sharma R; Donadeu FX; Baratta M
Cell Reprogram; 2015 Jun; 17(3):211-20. PubMed ID: 26053520
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of hematopoietic differentiation outcomes and molecular characterization reveals unbiased differentiation capacity and minor transcriptional memory in HPC/HSC-iPSCs.
Gao S; Hou X; Jiang Y; Xu Z; Cai T; Chen J; Chang G
Stem Cell Res Ther; 2017 Jan; 8(1):13. PubMed ID: 28114969
[TBL] [Abstract][Full Text] [Related]
4. Somatic transcriptome priming gates lineage-specific differentiation potential of human-induced pluripotent stem cell states.
Lee JH; Lee JB; Shapovalova Z; Fiebig-Comyn A; Mitchell RR; Laronde S; Szabo E; Benoit YD; Bhatia M
Nat Commun; 2014 Dec; 5():5605. PubMed ID: 25465724
[TBL] [Abstract][Full Text] [Related]
5. Preferential gene expression and epigenetic memory of induced pluripotent stem cells derived from mouse pancreas.
Nukaya D; Minami K; Hoshikawa R; Yokoi N; Seino S
Genes Cells; 2015 May; 20(5):367-81. PubMed ID: 25727848
[TBL] [Abstract][Full Text] [Related]
6. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
[TBL] [Abstract][Full Text] [Related]
7. Dynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cells.
Ji H; Zhang X; Oh S; Mayhew CN; Ulm A; Somineni HK; Ericksen M; Wells JM; Khurana Hershey GK
J Allergy Clin Immunol; 2015 Jan; 135(1):236-44. PubMed ID: 25441642
[TBL] [Abstract][Full Text] [Related]
8. Generation of Progesterone-Responsive Endometrial Stromal Fibroblasts from Human Induced Pluripotent Stem Cells: Role of the WNT/CTNNB1 Pathway.
Miyazaki K; Dyson MT; Coon V JS; Furukawa Y; Yilmaz BD; Maruyama T; Bulun SE
Stem Cell Reports; 2018 Nov; 11(5):1136-1155. PubMed ID: 30392973
[TBL] [Abstract][Full Text] [Related]
9. Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential.
Chuang CY; Huang MC; Chen HF; Tseng LH; Yu CY; Stone L; Huang HP; Ho HN; Kuo HC
Stem Cell Res Ther; 2015 Feb; 6(1):14. PubMed ID: 25889179
[TBL] [Abstract][Full Text] [Related]
10. Cell type of origin influences iPSC generation and differentiation to cells of the hematoendothelial lineage.
Phetfong J; Supokawej A; Wattanapanitch M; Kheolamai P; U-Pratya Y; Issaragrisil S
Cell Tissue Res; 2016 Jul; 365(1):101-12. PubMed ID: 26893154
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of RPE cells from integration-free iPS cells and their cell biological characterization.
Hazim RA; Karumbayaram S; Jiang M; Dimashkie A; Lopes VS; Li D; Burgess BL; Vijayaraj P; Alva-Ornelas JA; Zack JA; Kohn DB; Gomperts BN; Pyle AD; Lowry WE; Williams DS
Stem Cell Res Ther; 2017 Oct; 8(1):217. PubMed ID: 28969679
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the heterogeneity in DNA methylation patterns during stem cell differentiation and reprogramming.
Shao X; Zhang C; Sun MA; Lu X; Xie H
BMC Genomics; 2014 Nov; 15(1):978. PubMed ID: 25404570
[TBL] [Abstract][Full Text] [Related]
13. Cell reprogramming into the pluripotent state using graphene based substrates.
Yoo J; Kim J; Baek S; Park Y; Im H; Kim J
Biomaterials; 2014 Sep; 35(29):8321-9. PubMed ID: 24996757
[TBL] [Abstract][Full Text] [Related]
14. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells.
Lister R; Pelizzola M; Kida YS; Hawkins RD; Nery JR; Hon G; Antosiewicz-Bourget J; O'Malley R; Castanon R; Klugman S; Downes M; Yu R; Stewart R; Ren B; Thomson JA; Evans RM; Ecker JR
Nature; 2011 Mar; 471(7336):68-73. PubMed ID: 21289626
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Variation between Human Induced Pluripotent Stem Cell Lines Is an Indicator of Differentiation Capacity.
Nishizawa M; Chonabayashi K; Nomura M; Tanaka A; Nakamura M; Inagaki A; Nishikawa M; Takei I; Oishi A; Tanabe K; Ohnuki M; Yokota H; Koyanagi-Aoi M; Okita K; Watanabe A; Takaori-Kondo A; Yamanaka S; Yoshida Y
Cell Stem Cell; 2016 Sep; 19(3):341-54. PubMed ID: 27476965
[TBL] [Abstract][Full Text] [Related]
16. Dynamically reorganized chromatin is the key for the reprogramming of somatic cells to pluripotent cells.
Huang K; Zhang X; Shi J; Yao M; Lin J; Li J; Liu H; Li H; Shi G; Wang Z; Zhang B; Chen J; Pan G; Jiang C; Pei D; Yao H
Sci Rep; 2015 Dec; 5():17691. PubMed ID: 26639176
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
18. The Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells.
Brix J; Zhou Y; Luo Y
J Genet Genomics; 2015 Dec; 42(12):661-70. PubMed ID: 26743984
[TBL] [Abstract][Full Text] [Related]
19. Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities.
Wang XM; Yik WY; Zhang P; Lu W; Huang N; Kim BR; Shibata D; Zitting M; Chow RH; Moser AB; Steinberg SJ; Hacia JG
Stem Cell Res Ther; 2015 Aug; 6():158. PubMed ID: 26319495
[TBL] [Abstract][Full Text] [Related]
20. Direct Reprogramming of Fibroblasts to Astrocytes Using Small Molecules.
Tian E; Zhang M; Shi Y
Methods Mol Biol; 2021; 2352():45-55. PubMed ID: 34324179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
